Bulletin
Investor Alert

New York Markets Close in:

Intellia Therapeutics Inc.

NAS: NTLA

GO
/marketstate/country/us

Countdown to close

 --Real time quotes

Mar 24, 2023, 3:57 p.m.

/zigman2/quotes/207821052/composite

$

38.09

Change

+0.91 +2.45%

Volume

Volume 532,404

Real time quotes

/zigman2/quotes/207821052/composite

Previous close

$ 37.18

$ 38.09

Change

+0.91 +2.45%

Day low

Day high

$36.46

$38.40

Open

52 week low

52 week high

$32.44

$78.58

Open

Derek Hicks

Transactions

Date Shares Transaction Value
01/04/2023 1,812   Disposition at $37.21 per share. 67,425
01/03/2022 19,118   Award at $0 per share. 0

Officers and Executives

Dr. John M. Leonard
President, Chief Executive Officer & Director
Mr. Glenn Goddard
Treasurer, Chief Financial & Accounting Officer
Dr. Laura Sepp-Lorenzino
Chief Scientific Officer & Executive VP
Dr. Eliana Clark
Chief Technology Officer & Executive VP
Dr. David Lebwohl
Chief Medical Officer & Executive Vice President
Dr. Christine Foster
SVP-Business Development & Alliance Management
Mr. Derek Hicks
Chief Business Officer & Executive Vice President
Mr. Ian Karp
Senior Vice President-Corporate Communications
Ms. Marika St Amand
Chief Human Resources Officer
Mr. James Basta
Secretary, Executive VP & General Counsel
Dr. Aron Stein
Senior Vice President-Regulatory Affairs
Dr. Frank A. G. M. Verwiel
Chairman
Mr. John Francis Crowley
Independent Director
Dr. Georgia Keresty
Independent Director
Ms. Muna Bhanji
Independent Director
Dr. Jean-Francois B. Formela
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Jesse L. Goodman
Independent Director
Dr. Fred Ehrenkranz Cohen
Independent Director
Link to MarketWatch's Slice.